Who Should Not Take Peptide Injections? Side Effects, Interactions & Warning Signs
Quick answer: Some people should avoid specific peptide injections, while others may need additional screening or monitoring before treatment. Important considerations can include active or previous cancer, pregnancy, pituitary or endocrine disorders, diabetes or abnormal glucose control, cardiovascular or kidney disease, medication interactions, allergies and previous serious reactions. The risks and contraindications are not the same for every peptide.
This guide explains who may not be a candidate for peptide injections, common downsides, why some people feel unusual after treatment, what should not be mixed with certain peptides, and which warning signs require medical attention.
There Is No Universal “Peptide Contraindication List”
Peptide injections are not one medication. Tesamorelin, Sermorelin, Ipamorelin, CJC-1295, BPC-157, TB-500, MOTS-c and peptide blends have different targets, evidence, regulatory status and safety considerations.
The useful question is: is this specific product appropriate for me, given my medical history, medications, symptoms and goals?
For broader information on sourcing, compounding and monitoring, read our peptide injection safety guide.
Who Should Not Take Peptide Injections?
Eligibility depends on the specific peptide. Some conditions are formal contraindications for particular drugs; others require additional evaluation or caution.
Active or Previous Cancer
Cancer history can be relevant for therapies affecting growth-hormone or growth-factor pathways. This does not mean peptides broadly cause cancer.
Pregnancy or Breastfeeding
Pregnancy is a formal contraindication for tesamorelin. For many other products, adequate pregnancy or breastfeeding safety data may be absent.
Pituitary or Endocrine Disorders
Some GH-related therapies may be inappropriate or require special evaluation in patients with pituitary, hypothalamic or endocrine disorders.
Diabetes or Glucose Problems
Some GH-related therapies can affect glucose regulation. Diabetes, prediabetes and related medications should be reviewed.
Cardiovascular or Kidney Disease
Blood pressure, heart rate, edema, kidney function and cardiovascular medications may matter depending on treatment.
Previous Serious Reactions
Known hypersensitivity, unexplained symptoms or a prior serious reaction should be discussed before another injection.
What Is the Downside of Taking Peptides?
- Known side effects vary by specific drug.
- Unknown risks matter for compounds with limited human data.
- Hormonal and metabolic effects can occur with some GH/IGF-1-related therapies.
- Cardiovascular considerations may include fluid balance, heart rate or other issues depending on the product.
- Injection risks include irritation, infection, sterility and storage problems.
- Dosing errors can occur when mg, mcg, mL and U-100 units are confused.
- Product-quality uncertainty is important with compounded or unapproved products.
Side Effects Depend on the Specific Peptide
General peptide side-effect lists can be misleading because each therapy has a different evidence base and risk profile. Use the safety guide for the actual treatment being considered:
Why Do I Feel Weird After Peptides?
“Feeling weird” can describe headache, dizziness, nausea, fatigue, flushing, swelling, insomnia, anxiety, appetite changes, glucose changes or local injection reactions. It is not a diagnosis.
The cause may be the product, dose, formulation, another medication or supplement, dehydration, anxiety around injections, an unrelated illness or another medical problem. Significant new symptoms should not automatically be managed by changing the dose yourself.
For redness, soreness, swelling or other administration-related concerns, review our educational peptide injection sites and at-home injection guide. Medication-specific instructions from your provider and dispensing pharmacy should take priority.
When Should You Contact Your Provider or Seek Urgent Care?
Contact Your Prescribing Provider
- Persistent headache or dizziness
- New or significant swelling
- Persistent nausea or vomiting
- Insomnia or major sleep changes
- Significant mood or behavioral changes
- Unexpected glucose changes
- Worsening injection-site symptoms
Seek Urgent or Emergency Evaluation
- Chest pain
- Difficulty breathing
- Fainting
- Severe allergic reaction
- Severe confusion
- New neurologic symptoms
- Another severe or rapidly worsening reaction
What Should You Not Mix With Peptides?
There is no universal list of medications or supplements that cannot be combined with every peptide. The right question is what should not be combined with the specific therapy being considered for the specific patient.
Your provider should know about all prescription drugs, OTC medications, vitamins, supplements, hormones, steroids, diabetes medications, cardiovascular medications and other peptides you use.
Other GH or Hormone Therapies
Overlapping endocrine pathways can complicate effects and monitoring.
Diabetes Medications
Some GH-related therapies can affect glucose regulation.
Cardiovascular Medications
Blood pressure, heart rate, edema and cardiovascular history may be relevant.
Other Peptides & Supplements
Multiple products can make it harder to identify which substance caused a reaction.
Why Peptide “Stacking” Can Make Side Effects Harder to Understand
Combining CJC-1295, Ipamorelin, BPC-157, TB-500, hormones, supplements or other products can make a new symptom much harder to interpret. The issue may be one ingredient, an interaction, the combination, concentration, product quality or something unrelated.
Tell your clinician about all supplements, hormones and peptides you use, including products obtained without a prescription.
Safety Considerations Differ by Peptide
| Therapy | Important Safety Context |
|---|---|
| Tesamorelin | FDA-approved product exists for a specific indication; malignancy, IGF-1, glucose, fluid retention and formal contraindications can matter. |
| Sermorelin | Acts on GH-related pathways; endocrine history and individualized monitoring may be relevant. |
| Ipamorelin | FDA has identified limited safety information and compounding-related concerns, including potential immunogenicity and impurities. |
| CJC-1295 | Clinical data are limited; FDA notes reported serious adverse events including increased heart rate and systemic vasodilatory reaction. |
| BPC-157 | FDA reports limited safety information and insufficient information to know whether proposed routes would cause harm. |
| TB-500 | FDA reports no identified human exposure data for the substance it evaluated and lacks important safety information. |
| Wolverine Blend | Combines BPC-157 and TB-500; combining substances does not remove their individual uncertainties. |
| MOTS-c | FDA reports no identified human exposure data in drug products and lacks important safety information. |
Peptide Injection Safety FAQs
Who should avoid peptide injections?
It depends on the specific product. Cancer history, pregnancy, endocrine disease, glucose problems, cardiovascular disease, allergies and other conditions may be relevant, but formal contraindications differ by drug.
Why do peptides make me feel strange?
Possible explanations include adverse effects, dose or formulation issues, interactions, anxiety, dehydration or an unrelated medical problem. Persistent or significant symptoms should be reviewed by a clinician.
Can I take several peptides together?
Do not assume combinations are safe simply because each product is marketed separately. Combining products can complicate effects, interactions and identification of side effects.
What medications should not be mixed with peptides?
There is no universal prohibited list for all peptides. Medication interactions should be reviewed for the specific peptide and the patient’s complete medication and supplement list.
Should I stop a peptide if I have side effects?
Contact the prescribing clinician for individualized advice. Severe or rapidly worsening symptoms may require urgent or emergency evaluation.
Are compounded peptides FDA-approved?
No. Compounded drugs are not FDA-approved and FDA does not review them for safety, effectiveness or quality before marketing.
Sources & Medical References
Key safety statements in this article are based on current U.S. regulatory and prescribing information. These references are provided for patients who want to review the underlying guidance directly.
- 1U.S. Food & Drug Administration (FDA). Understanding the Risks of Compounded Drugs. FDA explains that compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness or quality before marketing. FDA Compounding Safety →
- 2U.S. Food & Drug Administration (FDA). Certain Bulk Drug Substances for Use in Compounding That May Present Significant Safety Risks. Includes FDA safety information and data limitations involving CJC-1295, Ipamorelin, MOTS-c, injectable GHK-Cu and other substances. FDA Peptide & Compounding Safety →
- 3DailyMed / U.S. National Library of Medicine. EGRIFTA WR (tesamorelin) Prescribing Information. Includes contraindications, malignancy warnings, IGF-1 monitoring, fluid retention, glucose intolerance and pregnancy information. Tesamorelin Prescribing Information →
- 4U.S. Food & Drug Administration (FDA) — BeSafeRx. Guidance for recognizing safe and unsafe online pharmacies, including prescription requirements, pharmacy licensing and pharmacist availability. FDA BeSafeRx →
Have Questions About Peptide Eligibility, Side Effects or Interactions?
A licensed provider can review your medical history, medications, symptoms and the specific peptide being considered before a treatment decision is made.
-
Monday – Friday:: 9:00 AM – 8:00 PMSaturday:: 9:00 AM – 4:00 PMSunday:: 12:00 PM – 8:00 PM